The existence in man of an alcohol-inducible liver cytochrome P450 isozyme, distinct in its capacity to metabolize ethanol and other compounds of pharmacological and/or toxicological importance, is now established. However, the actual role of this microsomal enzyme, termed P450-ALC, in human diseases states promoted by chronic alcohol consumption is ill-defined at present. To that end, we will expand on our initial studies concerning the characterization of purified human liver P450-ALC. The physical properties of P450-ALC proteins isolated from different human livers will first be compared in terms of NH2-terminal amino acid sequence, amino acid composition, proteolytic digestion mapping, and spectral characteristics. The capacity of these different human P450-ALC preparations to metabolize relevant substrates, including ethanol, acetaminophen, acetone, N- nitrosodimethylamine and carbon tetrachloride, will then be examined in a reconstituted system. Our objective here is to assess whether differences exist among individuals in P450-ALC catalytic properties and, if such differences exists, whether they result from alterations in enzyme structure. The mechanisms of ethanol oxidation by human P450-ALC will be studied in detail, particularly with regard to the capacity of this hemeprotein to generate reactive metabolites other than acetaldehyde. Antibodies directed against P450-ALC will then be used in immunoquantitation and immunoinhibition studies to gain insight into this protein's role in metabolism of the aforementioned substrates by human liver microsomes. These immunochemical studies may further aid in revealing functional variations in P450- ALC among individuals. We will also investigate, on a molecular basis, the expression of P450-ALC and its inducibility by ethanol consumption in alcoholic and non-alcoholic subjects using both antibodies and cloned cDNAs. Both P450-ALC cDNA and genomic DNA clones will be employed to assess whether a) restriction fragment length polymorphisms exist in or near the P450-ALC structural gene and b) if such polymorphic DNA regions encode for a catalytically-altered protein product or give rise to genetic variation in P450-ALC expression and/or inducibility. Our overall goal is to describe, in precise biochemical terms, the relation of P450-ALC to those human pathologies caused by excessive alcohol consumption and, ultimately, to the genetic predisposition to alcoholism.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
1R01AA007842-01
Application #
3111783
Study Section
Alcohol Biomedical Research Review Committee (ALCB)
Project Start
1988-09-01
Project End
1991-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Savas, Uzen; Machemer, Daniel E W; Hsu, Mei-Hui et al. (2009) Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model. J Biol Chem 284:16541-52
Hirani, Vandana; Yarovoy, Anton; Kozeska, Anita et al. (2008) Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. Arch Biochem Biophys 478:59-68
Dhar, Madhurima; Sepkovic, Daniel W; Hirani, Vandana et al. (2008) Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. J Lipid Res 49:612-24
Raucy, Judy L; Lasker, Jerome; Ozaki, Kazuaki et al. (2004) Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol Sci 79:233-41
Hirani, Vandana N; Raucy, Judy L; Lasker, Jerome M (2004) Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19. Drug Metab Dispos 32:1462-7
Raucy, Judy L; Mueller, Lisa; Duan, Kui et al. (2002) Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J Pharmacol Exp Ther 302:475-82
Lasker, J M; Chen, W B; Wolf, I et al. (2000) Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 275:4118-26
Cummings, B S; Lasker, J M; Lash, L H (2000) Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J Pharmacol Exp Ther 293:677-85
Wester, M R; Lasker, J M; Johnson, E F et al. (2000) CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Drug Metab Dispos 28:354-9
Pan-Zhou, X R; Cretton-Scott, E; Zhou, X J et al. (1998) Role of human liver P450s and cytochrome b5 in the reductive metabolism of 3'-azido-3'-deoxythymidine (AZT) to 3'-amino-3'-deoxythymidine. Biochem Pharmacol 55:757-66

Showing the most recent 10 out of 26 publications